Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ·Healthcare·Biotechnology
$6.56
-3.88%
Mkt Cap $53.91M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+159.1%
Consensus $17.00 vs current $6.56
NASDAQ·Healthcare·Biotechnology
$6.56
-3.88%
Mkt Cap $53.91M
No recent rating data.
Price Target (4 analysts)
$17.00
Range $17.00 – $17.00
+159.1%
Consensus $17.00 vs current $6.56